Live Breaking News & Updates on Acute Heart Failure
Stay updated with breaking news from Acute heart failure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Anhydrous Hydrogen Fluoride Market Worth USD 5274.7 Million openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Anhydrous Hydrogen Fluoride (AHF) Market to Witness Huge Growth openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
1. This multicentre, randomized, comparative effectiveness study found that the short-stay unit (SSU) was often as effective as hospitalization in patients with new onset of acute heart failure (AHF) and otherwise low-risk profiles. 2. There was no difference in 30- and 90-day mortality between the SSU and hospitalized patients. Evidence Rating Level: 1 (Excellent) Patients ....